Warfarin Sodium has 74 known drug interactions based on U.S. FDA drug labeling data. 55 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Acyclovir, Allopurinol, Alprazolam. Patients taking Warfarin Sodium should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 74
- Major
- 55
- Moderate
- 3
Major (55)
- Warfarin Sodium + Acyclovir— CYP1A2 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Allopurinol— CYP1A2 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Alprazolam— CYP3A4 inhibitor that increases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Amiodarone— CYP2C9 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Amlodipine— CYP3A4 inhibitor that increases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Amprenavir— CYP3A4 inhibitor that increases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Aprepitant— CYP2C9 inducer that decreases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Atazanavir— CYP3A4 inhibitor that increases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Atorvastatin— CYP3A4 inhibitor that increases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Bicalutamide— CYP3A4 inhibitor that increases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Bosentan— CYP2C9 inducer that decreases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Caffeine— CYP1A2 inhibitor that increases warfarin effect and INR; requires close INR monitoring.
- Warfarin Sodium + Capecitabine— CYP2C9 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Carbamazepine— CYP2C9 inducer that decreases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Cilostazol— CYP3A4 inhibitor that increases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Cimetidine— CYP1A2 inhibitor that increases warfarin effect and INR; requires close INR monitoring.
- Warfarin Sodium + Ciprofloxacin— CYP1A2 inhibitor that increases warfarin effect and INR; requires close INR monitoring.
- Warfarin Sodium + Clarithromycin— CYP3A4 inhibitor that increases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Conivaptan— CYP3A4 inhibitor that increases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Cotrimoxazole— CYP2C9 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Cyclosporine— CYP3A4 inhibitor that increases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Darunavir— CYP3A4 inhibitor that increases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Disulfiram— CYP1A2 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Enoxacin— CYP1A2 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Etravirine— CYP2C9 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Famotidine— CYP1A2 inhibitor that increases warfarin effect and INR; requires close INR monitoring.
- Warfarin Sodium + Fluconazole— CYP2C9 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Fluvastatin— CYP2C9 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Fluvoxamine— CYP2C9 and CYP1A2 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Heparin Sodium— Heparin may prolong prothrombin time; at least 5 hours after IV or 24 hours after SC heparin dose should elapse before b…
- Warfarin Sodium + Methoxsalen— CYP1A2 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Metronidazole— CYP2C9 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Mexiletine— CYP1A2 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Miconazole— CYP2C9 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Montelukast— CYP1A2 and CYP3A4 inducer that decreases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Moricizine— CYP1A2 inducer that decreases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Norfloxacin— CYP1A2 inhibitor that increases warfarin effect and INR; requires close INR monitoring.
- Warfarin Sodium + Omeprazole— CYP1A2 and CYP3A4 inducer that decreases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Oral Contraceptives— CYP1A2 inhibitor that increases warfarin effect and INR; requires close INR monitoring.
- Warfarin Sodium + Oxandrolone— CYP2C9 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Phenobarbital— CYP2C9 inducer that decreases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Phenylpropanolamine— CYP1A2 inhibitor that increases warfarin effect and INR; requires close INR monitoring.
- Warfarin Sodium + Phenytoin— CYP1A2 and CYP3A4 inducer that decreases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Propafenone— CYP1A2 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Propranolol— CYP1A2 inhibitor that increases warfarin effect and INR; requires close INR monitoring.
- Warfarin Sodium + Rifampin— CYP2C9 inducer that decreases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Sulfinpyrazone— CYP2C9 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Terbinafine— CYP1A2 inhibitor that increases warfarin effect and INR; requires close INR monitoring.
- Warfarin Sodium + Thiabendazole— CYP1A2 inhibitor that increases warfarin effect and INR; requires close INR monitoring.
- Warfarin Sodium + Ticlopidine— CYP1A2 inhibitor that increases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Tigecycline— CYP2C9 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Verapamil— CYP1A2 inhibitor that increases warfarin effect and INR; requires close monitoring.
- Warfarin Sodium + Voriconazole— CYP2C9 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Zafirlukast— CYP2C9 inhibitor that increases warfarin effect and INR; requires closer INR monitoring.
- Warfarin Sodium + Zileuton— CYP1A2 inhibitor that increases warfarin effect and INR; requires close monitoring.
Moderate (3)
- Warfarin Sodium + Acetaminophen— Chronic oral acetaminophen use at 4000 mg/day increases INR in some patients stabilized on warfarin. More frequent INR a…
- Warfarin Sodium + Acetaminophen And Codeine Phosphate— Chronic acetaminophen use at 4000 mg/day may increase INR in patients stabilized on warfarin. More frequent INR assessme…
- Warfarin Sodium + Fondaparinux Sodium— Concomitant use did not significantly affect pharmacokinetics/pharmacodynamics in clinical studies. Monitor for hemorrha…